AACC 2014: BIT Group to Highlight Newest In-Vitro Diagnostic Instrumentation Technology

BIT Group, with global team representatives from the US, China, Japan, Germany and France, will be exhibitors at the 2014 annual meeting of the American Association of Clinical Chemistry (AACC) in Chicago, Illinois on July 27-July 31.

BIT will be showcasing its white-label instruments as well as its modular BIT SMARTSOLUTIONS™ proprietary platform architecture which enables rapid development of custom instruments for a global audience. Team members from the company‘s numerous global sites will be available to discuss the latest advancements in technology. Anyone interested in scheduling an appointment during the expo can contact BIT Group at +1 858-613-1200 ext. 214. All others can simply stop by Booth #1241 to meet with BIT Group representatives.

The annual conference of the AACC is the world’s largest exhibition for in-vitro diagnostic instrumentation, presenting a stage where attendees can gain insight into the latest technologies and developments in the industry. This year’s gathering of experts from the field of laboratory medicine will feature more than 770 exhibitors occupying more than 2000 booths. All will be focused on presenting the very latest developments in clinical diagnostic technology.

Source: http://www.bit-group.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.